Skip to main content
. 2019 Apr 9;42(6):1120–1128. doi: 10.2337/dc18-2147

Table 1.

Baseline characteristics of participants stratified by sex

Overall (n = 539) Female (n = 344) Male (n = 195) P value for difference by sex
Female 63.8
Age (years) 13.9 ± 2.0 13.6 ± 2.0 14.4 ± 1.9 <0.0001
Diabetes duration (months) 7.9 ± 5.9 8.1 ± 6.0 7.5 ± 5.7 NS
Race/ethnicity
 Black non-Hispanic 33.6 36.0 29.2 NS
 Hispanic 43.0 41.3 46.2
 White non-Hispanic 20.0 18.3 23.1
 Other 3.3 4.4 1.5
Tanner stage
 4–5 89.8 90.4 88.7 NS
 <4 10.2 9.6 11.3
BMI (kg/m2) 34.6 ± 7.8 34.3 ± 7.5 35.2 ± 8.3 NS
Blood pressure (mmHg)
 Systolic 112.7 ± 11.1 110.6 ± 10.4 116.5 ± 11.2 <0.0001
 Diastolic 66.4 ± 8.2 65.8 ± 8.3 67.4 ± 7.9 0.031
 Mean arterial pressure 81.8 ± 8.4 80.7 ± 8.4 83.8 ± 8.0 <0.0001
ACE inhibitor/ARB use 4.6 4.9 4.1 NS
Lipid-lowering medication use 0.9 1.2 0.5 NS
UACR (mg/g)* 30.5 ± 116.0, 7 (8) 35.1 ± 128.9, 7 (10) 22.6 ± 88.9, 6 (8) 0.043
Serum cystatin-C (mg/L) 0.75 ± 0.12 0.72 ± 0.11 0.80 ± 0.11 <0.0001
Serum creatinine (mg/dL) 0.61 ± 0.13 0.58 ± 0.11 0.66 ± 0.13 <0.0001
eGFR (mL/min/1.73 m2)
 Zappitelli combined equation 109.7 ± 15.1 112.2 ± 15.2 105.3 ± 13.9 <0.0001
 FAS equation 116.7 ± 16.4 119.6 ± 16.4 111.6 ± 15.2 <0.0001
HbA1c (%) 6.0 ± 0.7 6.0 ± 0.7 5.9 ± 0.7 NS
Insulin sensitivity (1/IF) (mL/µU)* 0.05 ± 0.05 0.05 ± 0.04 0.05 ± 0.04 NS
HDL cholesterol (mg/dL) 38.9 ± 8.8 39.7 ± 9.0 37.3 ± 8.1 0.0021
Triglycerides (mg/dL)* 113.6 ± 74.3 112.0 ± 69.6 116.6 ± 82.0 NS
Triglycerides–to–HDL cholesterol ratio 3.1 ± 2.3 3.1 ± 2.2 3.3 ± 2.5 NS
hs-CRP (mg/dL)* 0.44 ± 0.88 0.43 ± 0.64 0.45 ± 1.21 NS
SUA (mg/dL) 5.83 ± 1.41 5.36 ± 1.17 6.65 ± 1.43 <0.0001
SUA ≥6.8 mg/dL 25.6 11.6 50.3 <0.0001

Data are presented as mean ± SD or percentage, and for UACR, the median (interquartile) is also given. P values for differences by sex were calculated from F tests or χ2 tests. ARB, angiotensin-receptor blocker; IF, fasting insulin.

*Variables were log-transformed before testing.